Idiopathic hypercalciuria

Current Rheumatology Reports

Volumn 8, Issue 1, 2006, Pages 70-75

  Liebman, Scott E ^a   Taylor, Jeremy G ^b   Bushinsky, David A ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; CALCIUM; CHLORTALIDONE; THIAZIDE DIURETIC AGENT; TRIAMTERENE;

CALCIUM HOMEOSTASIS; CALCIUM INTAKE; CALCIUM STONE; CALCIUM TRANSPORT; CALCIUM URINE LEVEL; CLINICAL TRIAL; DIET THERAPY; FLUID INTAKE; HUMAN; HYPOKALEMIA; IDIOPATHIC HYPERCALCIURIA; NEPHROLITHIASIS; NONHUMAN; PATHOGENESIS; REVIEW; SODIUM RESTRICTION; URINARY EXCRETION;

ANIMALS; BONE AND BONES; CALCIUM; HUMANS; HYPERCALCIURIA; INTESTINES; KIDNEY; NEPHROLITHIASIS;

EID: 33747336140     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-006-0029-z     Document Type: Review

References (43)

1. Monk RD, Bushinsky DA: Kidney stones. In Williams Textbook of Endocrinology. Edited by Larsen PR, Kronenberg HM, Melmed S, Polonsky KS. Philadelphia: WB Saunders; 2003:1411-1425.
2. Monk RD, Bushinsky DA: Nephrolithiasis and nephrocalcinosis. In Comprehensive Clinical Nephrology. Edited by Johnson R, Frehally I. London: Mosby; 2003:731-744.
3. Coe FL, Evan A, Worcester E: Kidney stone disease. J Clin Invest 2005, 115:2598-2608. An excellent overall review of nephrolithiasis, including pathophysiology of stone formation, underlying genetic causes and a summary of clinical trials related to management.
4. Stamatelou KK, Francis ME, Jones CA, et al.: Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003, 63:1817-1823.
5. Pak CY: Kidney stones. Lancet 1998, 351:1797-1801.
6. Soucie JM, Thun MJ, Coates RJ, et al.: Demographic and geographic variability of kidney stones in the United States. Kidney Int 1994, 893-899.
7. Bushinsky DA: Kidney Stones. Adv Intern Med 2001, 47:219-238.
8. Frick KK, Bushinsky DA: Molecular mechanisms of primary hypercalciuria. J Am Soc Neph 2003, 14:1082-1095.
9. Levy FL, Adams-Huet B, Pak CY: Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 1995, 98:50-59.
10. Hoenderop JGJ, Nilius B, Bindels RJM: Calcium absorption across epithelia. Physiol Revs 2005, 85:373-422. A comprehensive review of calcium transport, especially in the intestine and kidney, with an emphasis on newly discovered molecular mechanisms.
11. Bronner F, Pansu D: Nutritional aspects of calcium absorption. J Nutr 1999, 129:9-12.
12. Suda T, Ueno Y, Fujji Y, Shinki T: Vitamin D and bone. J Cell Biochem 2003, 88:259-266. An overview of the molecular effects of Vitamin D on bone formation and resorption.
13. Ba J, Friedman PA: Calcium-sensing receptor regulation of renal mineral ion transport. Cell Calcium 2004, 35:229-237.
14. Hoenderop JG, Muller D, van der Kemp AW, et al.: Cacitriol controls the epithelial calcium channel in kidney. J Am Soc Neph 2001, 12:1342-1349.
15. Hebert SC, Brown EM, Harris HW: Role of the Ca2+-sensing receptor in divalent mineral ion homeostasis. J Exp Biol 1997, 200:295-302.
16. Motoyama HI, Friedman PA: Calcium-sensing receptor regulation of PTH-dependent calcium absorption by mouse cortical ascending limbs. Am J Physiol Renal Physiol 2002, 283:F399-F406.
17. Pearce SH, Williamson C, Kifor O, et al.: A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 1996, 335:1115-1122.
18. Moe OW, Bonny O: Genetic hypercalciuria. J Am Soc Nephrol 2005, 16:729-745. A state of the art review outlining monogenetic and polygenetic abnormalities leading to hypercalciuria.
19. Yao J, Karnauskas AJ, Bushinsky DA, Favus MJ: Regulation of renal calcium-sensing receptor gene expression in response to 1,25(OH2D3) in genetic hypercalciuric stone forming rats. J Am Soc Nephrol 2005, 16:1300-1308.
20. Bushinsky DA, Asplin JR: Thiazides reduce brushite, but not calcium oxalate, supersaturation and stone formation in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol 2005, 16:417-424.
21. Karnauskas AJ, van Leeuwen JP, van den Bemd GJ: Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res 2005, 20:447-454.
22. Bushinsky DA, Grynpas MD, Nilsson EL, et al.: Stone formation in genetic hypercalciuric rats. Kidney Int 1995, 48:1705-1713.
23. Bushinsky DA, Asplin JR, Grynpas MD, et al.: Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 2002, 61:975-987.
24. Evan AP, Bledsoe SB, Smith SB, Bushinsky DA: Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats. Kidney Int 2004, 65:154-161.
25. Bushinsky DA, Favus MJ: Mechanism of hypercalciuria in genetic hypercalciuric rats: inherited defect in intestinal calcium transport. J Clin Invest 1988, 82:1585-1591.
26. Kim M, Sessler NE, Tembe V, et al.: Response of genetic hypercalciuric rats to a low calcium diet. Kidney Int 1993, 43:189-196.
27. Yao J, Kathpalia P, Bushinsky DA, Favus MJ: Hyper-responsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3: a new characteristic of genetic hypercalciuric stone-forming rats. J Clin Invest 1998, 101:2223-2232.
28. Li X-Q, Tembe V, Horwitz GM, et al.: Increased intestinal vitamin D receptor in genetic hypercalciuric rats: a cause of intestinal calcium hyperabsorption. J Clin Invest 1993, 91:661-667.
29. Krieger NS, Stathopoulos VM, Bushinsky DA: Increased sensitivity to 1,25(OH)2D3 in bone from genetic hypercalciuric rats. Am J Physiol (Cell Physiol) 1996, 271:C130-C135.
30. Tsuruoka S, Bushinsky DA, Schwartz GJ: Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int 1997, 51:1540-1547.
31. Bushinsky DA, Neumann KJ, Asplin J, Krieger NS: Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats. Kidney Int 1999, 55:234-243.
32. Hoopes RR, Reid R, Sen S, et al.: Quantitative trait loci for hypercalciuria in a rat model of kidney stone disease. J Am Soc Nephrol 2003, 14:1844-1850.
33. Favus MJ, Karnauskas AJ, Parks JH, Coe FL: Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab 2004, 89:4937-4943.
34. Borghi L, Meschi T, Amato F, et al.: Urinary volume, water, and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 1996, 155:839-843.
35. Lemann J, Jr., Bushinsky DA, Hamm LL: Bone buffering of acid and base in humans. Am J Physiol Renal Physiol 2003, 285:F811-F832.
36. Bataille P, Charransol G, Gregoire I, et al.: Effect of calcium restriction on renal excretion of oxalate and the probability of stones in the various pathophysiological groups with calcium stones. J Urol 1983, 130:218.
37. Borghi L, Schianchi T, Meschi T, et al.: A randomized trial comparing two diets for the prevention of stone recurrences in idiopathic hypercalciuria. N Engl J Med 2002, 346:77-84.
38. Coe FL, Parks JH, Bushinsky DA, et al.: Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int 1988, 33:1140-1146.
39. Laerum E, Larsen S: Thiazide prophylaxis of urolithiasis: a double-blind study in general practice. Acta Med Scand 1984, 215:383-389.
40. Ettinger B, Citron JT, Livermore B, Dolman LI: Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 1988, 139:679-684.
41. Borghi L, Meschi T, Guerra A, Novarini A: Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovascular Pharm 1993, 22:S78-S86.
42. Ettinger B, Pak CY, Citron JT, et al.: Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 1997, 158:2069-2073.
43. Barcelo P, Wuhl O, Servitge E, et al.: Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 1993, 150:1761-1764.